The Company
Starton is a clinical-stage biotechnology company focused on transforming standard of care therapeutics. Starton uses proven technology with proprietary drivers to obtain new indications or develop on-label superiority with a focus on hematology and oncology.
(formerly known as Chemiocare)
The Partnership
Impactreneur is an early stage equity investor
View our other investments
